The Journal of Experimental Medicine · 1998 · 646 citations · 43 references
Life SciencesCell BiologyImmunologyCellular ImmunologyInnate ImmunityMolecular ImmunologyAntigen RecognitionNatural Killer Cell BiologyNatural Killer Cell FunctionT Cell ActivationT Cell BiologyT Cell Responses To TumorsKiller-cell Immunoglobulin-like ReceptorsNatural Killer Cell Receptor-ligand InteractionsPeripheral Blood Natural Killer CellsT Cell Epitope RecognitionT Cell Receptor DiversityT Cell Receptor Recognition
NK T cells are a lymphocyte subset with a distinct phenotype, an invariant TCR, and reactivity to CD1. Our data suggest that α‑GalCer could modulate human immune responses by activating the highly conserved NK T cell subset implicated in autoimmune disease and tumor control. Mouse or human CD1 molecules present α‑GalCer to NK T cells from either species. Mouse and human NK T cells recognize each other’s CD1d and both species’ CD1 molecules presenting α‑GalCer, and α‑GalCer stimulation expands invariant Vα24+ NK T cells and elicits large cytokine release, highlighting the system’s fundamental conservation.
Natural killer (NK) T cells are a lymphocyte subset with a distinct surface phenotype, an invariant T cell receptor (TCR), and reactivity to CD1. Here we show that mouse NK T cells can recognize human CD1d as well as mouse CD1, and human NK T cells also recognize both CD1 homologues. The unprecedented degree of conservation of this T cell recognition system suggests that it is fundamentally important. Mouse or human CD1 molecules can present the glycolipid α-galactosylceramide (α-GalCer) to NK T cells from either species. Human T cells, preselected for invariant Vα24 TCR expression, uniformly recognize α-GalCer presented by either human CD1d or mouse CD1. In addition, culture of human peripheral blood cells with α-GalCer led to the dramatic expansion of NK T cells with an invariant (Vα24+) TCR and the release of large amounts of cytokines. Because invariant Vα14+ and Vα24+ NK T cells have been implicated both in the control of autoimmune disease and the response to tumors, our data suggest that α-GalCer could be a useful agent for modulating human immune responses by activation of the highly conserved NK T cell subset.
43
CD1d-Restricted and TCR-Mediated Activation of V <sub>α</sub> 14 NKT Cells by Glycosylceramides
Tetsu Kawano, Junqing Cui, Yasuhiko Koezuka et al. · Science · 1997 · 2.4K citations
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Véronique M. Braud, David Allan, Christopher A. O'Callaghan et al. · Nature · 1998 · 2.2K citations
Requirement for V <sub>α</sub> 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Junqing Cui, Tahiro Shin, Tetsu Kawano et al. · Science · 1997 · 1.2K citations
Olivier Lantz, Albert Bendelac · The Journal of Experimental Medicine · 1994 · 1K citations · Full text
CD1 Recognition by Mouse NK1 <sup>+</sup> T Lymphocytes
Albert Bendelac, Olivier Lantz, Mary E. Quimby et al. · Science · 1995 · 902 citations